Development of a physiologically-based pharmacokinetic model of the rat central nervous system

Raj K. Singh Badhan , Marylore Chenel, Jeffrey I. Penny

Research output: Contribution to journalArticle

Abstract

Central nervous system (CNS) drug disposition is dictated by a drug’s physicochemical properties and its ability to permeate physiological barriers. The blood–brain barrier (BBB), blood-cerebrospinal fluid barrier and centrally located drug transporter proteins influence drug disposition within the central nervous system. Attainment of adequate brain-to-plasma and cerebrospinal fluid-to-plasma partitioning is important in determining the efficacy of centrally acting therapeutics. We have developed a physiologically-based pharmacokinetic model of the rat CNS which incorporates brain interstitial fluid (ISF), choroidal epithelial and total cerebrospinal fluid (CSF) compartments and accurately predicts CNS pharmacokinetics. The model yielded reasonable predictions of unbound brain-to-plasma partition ratio (Kpuu,brain) and CSF:plasma ratio (CSF:Plasmau) using a series of in vitro permeability and unbound fraction parameters. When using in vitro permeability data obtained from L-mdr1a cells to estimate rat in vivo permeability, the model successfully predicted, to within 4-fold, Kpuu,brain and CSF:Plasmau for 81.5% of compounds simulated. The model presented allows for simultaneous simulation and analysis of both brain biophase and CSF to accurately predict CNS pharmacokinetics from preclinical drug parameters routinely available during discovery and development pathways.

LanguageEnglish
Pages97-136
Number of pages40
JournalPharmaceutics
Volume6
Issue number1
DOIs
Publication statusPublished - 18 Mar 2014

Fingerprint

Cerebrospinal Fluid
Central Nervous System
Pharmacokinetics
Brain
Permeability
Pharmaceutical Preparations
Central Nervous System Agents
Extracellular Fluid
Blood-Brain Barrier
Proteins

Bibliographical note

This is an Open Access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited [Attribution 3.0 Unported (CC BY 3.0)].

Keywords

  • blood-brain barrier
  • brain
  • cerebrospinal fluid
  • physiologically-based pharmacokinetic model
  • unbound fraction

Cite this

@article{c399ab72f802442187a6a8f8ce2c5c4f,
title = "Development of a physiologically-based pharmacokinetic model of the rat central nervous system",
abstract = "Central nervous system (CNS) drug disposition is dictated by a drug’s physicochemical properties and its ability to permeate physiological barriers. The blood–brain barrier (BBB), blood-cerebrospinal fluid barrier and centrally located drug transporter proteins influence drug disposition within the central nervous system. Attainment of adequate brain-to-plasma and cerebrospinal fluid-to-plasma partitioning is important in determining the efficacy of centrally acting therapeutics. We have developed a physiologically-based pharmacokinetic model of the rat CNS which incorporates brain interstitial fluid (ISF), choroidal epithelial and total cerebrospinal fluid (CSF) compartments and accurately predicts CNS pharmacokinetics. The model yielded reasonable predictions of unbound brain-to-plasma partition ratio (Kpuu,brain) and CSF:plasma ratio (CSF:Plasmau) using a series of in vitro permeability and unbound fraction parameters. When using in vitro permeability data obtained from L-mdr1a cells to estimate rat in vivo permeability, the model successfully predicted, to within 4-fold, Kpuu,brain and CSF:Plasmau for 81.5{\%} of compounds simulated. The model presented allows for simultaneous simulation and analysis of both brain biophase and CSF to accurately predict CNS pharmacokinetics from preclinical drug parameters routinely available during discovery and development pathways.",
keywords = "blood-brain barrier, brain, cerebrospinal fluid, physiologically-based pharmacokinetic model, unbound fraction",
author = "Badhan, {Raj K. Singh} and Marylore Chenel and Penny, {Jeffrey I.}",
note = "This is an Open Access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited [Attribution 3.0 Unported (CC BY 3.0)].",
year = "2014",
month = "3",
day = "18",
doi = "10.3390/pharmaceutics6010097",
language = "English",
volume = "6",
pages = "97--136",
journal = "Pharmaceutics",
issn = "1999-4923",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "1",

}

Development of a physiologically-based pharmacokinetic model of the rat central nervous system. / Badhan , Raj K. Singh; Chenel, Marylore; Penny, Jeffrey I.

In: Pharmaceutics, Vol. 6, No. 1, 18.03.2014, p. 97-136.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development of a physiologically-based pharmacokinetic model of the rat central nervous system

AU - Badhan , Raj K. Singh

AU - Chenel, Marylore

AU - Penny, Jeffrey I.

N1 - This is an Open Access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited [Attribution 3.0 Unported (CC BY 3.0)].

PY - 2014/3/18

Y1 - 2014/3/18

N2 - Central nervous system (CNS) drug disposition is dictated by a drug’s physicochemical properties and its ability to permeate physiological barriers. The blood–brain barrier (BBB), blood-cerebrospinal fluid barrier and centrally located drug transporter proteins influence drug disposition within the central nervous system. Attainment of adequate brain-to-plasma and cerebrospinal fluid-to-plasma partitioning is important in determining the efficacy of centrally acting therapeutics. We have developed a physiologically-based pharmacokinetic model of the rat CNS which incorporates brain interstitial fluid (ISF), choroidal epithelial and total cerebrospinal fluid (CSF) compartments and accurately predicts CNS pharmacokinetics. The model yielded reasonable predictions of unbound brain-to-plasma partition ratio (Kpuu,brain) and CSF:plasma ratio (CSF:Plasmau) using a series of in vitro permeability and unbound fraction parameters. When using in vitro permeability data obtained from L-mdr1a cells to estimate rat in vivo permeability, the model successfully predicted, to within 4-fold, Kpuu,brain and CSF:Plasmau for 81.5% of compounds simulated. The model presented allows for simultaneous simulation and analysis of both brain biophase and CSF to accurately predict CNS pharmacokinetics from preclinical drug parameters routinely available during discovery and development pathways.

AB - Central nervous system (CNS) drug disposition is dictated by a drug’s physicochemical properties and its ability to permeate physiological barriers. The blood–brain barrier (BBB), blood-cerebrospinal fluid barrier and centrally located drug transporter proteins influence drug disposition within the central nervous system. Attainment of adequate brain-to-plasma and cerebrospinal fluid-to-plasma partitioning is important in determining the efficacy of centrally acting therapeutics. We have developed a physiologically-based pharmacokinetic model of the rat CNS which incorporates brain interstitial fluid (ISF), choroidal epithelial and total cerebrospinal fluid (CSF) compartments and accurately predicts CNS pharmacokinetics. The model yielded reasonable predictions of unbound brain-to-plasma partition ratio (Kpuu,brain) and CSF:plasma ratio (CSF:Plasmau) using a series of in vitro permeability and unbound fraction parameters. When using in vitro permeability data obtained from L-mdr1a cells to estimate rat in vivo permeability, the model successfully predicted, to within 4-fold, Kpuu,brain and CSF:Plasmau for 81.5% of compounds simulated. The model presented allows for simultaneous simulation and analysis of both brain biophase and CSF to accurately predict CNS pharmacokinetics from preclinical drug parameters routinely available during discovery and development pathways.

KW - blood-brain barrier

KW - brain

KW - cerebrospinal fluid

KW - physiologically-based pharmacokinetic model

KW - unbound fraction

UR - http://www.scopus.com/inward/record.url?scp=84897849102&partnerID=8YFLogxK

U2 - 10.3390/pharmaceutics6010097

DO - 10.3390/pharmaceutics6010097

M3 - Article

VL - 6

SP - 97

EP - 136

JO - Pharmaceutics

T2 - Pharmaceutics

JF - Pharmaceutics

SN - 1999-4923

IS - 1

ER -